{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:22:29Z","timestamp":1791994949806,"version":"4.4.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,7,8]],"date-time":"2019-07-08T00:00:00Z","timestamp":1562544000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi-Aventis","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009647","name":"Ministry of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009647","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010449","name":"Ministry of Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010449","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.ijid.2019.07.004","type":"journal-article","created":{"date-parts":[[2019,7,10]],"date-time":"2019-07-10T11:42:27Z","timestamp":1562758947000},"page":"21-29","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"special_numbering":"C","title":["Diagnosis and management of latent tuberculosis infection in Asia: Review of current status and challenges"],"prefix":"10.1016","volume":"87","author":[{"given":"Nicholas I.","family":"Paton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Borand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jubert","family":"Benedicto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar Mar","family":"Kyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asif Mujtaba","family":"Mahmud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd Nor","family":"Norazmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nandini","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charoen","family":"Chuchottaworn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Wen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nastiti","family":"Kaswandani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoi","family":"Le Van","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace C.Y.","family":"Lui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tan Eang","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2019.07.004_bib0005","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1471-2458-14-22","article-title":"Latent tuberculosis infection in a Malaysian prison: Implications for a comprehensive integrated control program in prisons","volume":"14","author":"Al-Darraji","year":"2014","journal-title":"BMC Public Health"},{"key":"10.1016\/j.ijid.2019.07.004_bib0010","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.diabres.2018.03.022","article-title":"Diabetes is associated with increased prevalence of latent tuberculosis infection: findings from the National Health and Nutrition Examination Survey, 2011-2012","volume":"139","author":"Barron","year":"2018","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"10.1016\/j.ijid.2019.07.004_bib0015","first-page":"3","article-title":"The incidence of active tuberculosis among health workers with latent tuberculosis infection in tertiary hospital settings","volume":"15","author":"Benedicto","year":"2012","journal-title":"Phil J Chest Dis"},{"issue":"9","key":"10.1016\/j.ijid.2019.07.004_bib0020","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.5588\/ijtld.14.0829","article-title":"Three months of weekly rifapentine plus isoniazid is less hepatotoxic than nine months of dailyisoniazid for LTBI","volume":"19","author":"Bliven-Sizemore","year":"2015","journal-title":"Int J Tuberc Lung Dis."},{"issue":"9","key":"10.1016\/j.ijid.2019.07.004_bib0025","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1001\/jama.2016.11021","article-title":"The challenge of latent TB infection","volume":"316","author":"Blumberg","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.ijid.2019.07.004_bib0030","series-title":"Taiwan Centre for Disease Control annual report","author":"Centers for Disease Control","year":"2018"},{"issue":"2","key":"10.1016\/j.ijid.2019.07.004_bib0035","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1164\/rccm.201305-0863OC","article-title":"Risk for tuberculosis in child contacts: Development and validation of a predictive score","volume":"189","author":"Chan","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ijid.2019.07.004_bib0040","article-title":"Experience from Taiwan: Political commitment for LTBI diagnosis and treatment","author":"Chan","year":"2018","journal-title":"Invited talk of 6th annual TB experts community meeting: getting to zero by addressing latent TB in Asia"},{"key":"10.1016\/j.ijid.2019.07.004_bib0045","first-page":"217","article-title":"The Singapore tuberculosis elimination programme: the first five years","volume":"81","author":"Chee","year":"2003","journal-title":"Bull World Health Organ"},{"issue":"6","key":"10.1016\/j.ijid.2019.07.004_bib0050","first-page":"35","article-title":"First screening and treatment campaign for latent tuberculosis infections in a mountainous township, Taiwan, 2016\u20132017","volume":"34","author":"Chen","year":"2018","journal-title":"Taiwan EB"},{"issue":"1","key":"10.1016\/j.ijid.2019.07.004_bib0055","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1093\/jac\/dky403","article-title":"Cost-effectiveness of 3 months of weekly rifapentine and isoniazid compared with other standard treatment regimens for latent tuberculosis infection: a decision analysis study","volume":"74","author":"Doan","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2019.07.004_bib0060","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1146\/annurev-publhealth-031912-114431","article-title":"Prospects for tuberculosis elimination","volume":"34","author":"Dye","year":"2013","journal-title":"Annu Rev Public Health"},{"key":"10.1016\/j.ijid.2019.07.004_bib0065","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ijid.2016.11.006","article-title":"Preventive therapy for latent tuberculosis infection\u2014the promise and the challenges","volume":"56","author":"Fox","year":"2017","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ijid.2019.07.004_bib0070","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1056\/NEJMra1405427","article-title":"Latent mycobacterium tuberculosis infection","volume":"372","author":"Getahun","year":"2015","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.ijid.2019.07.004_bib0075","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.5588\/ijtld.18.0168","article-title":"Three-month weekly rifapentine plus isoniazid for tuberculosis preventive treatment: a systematic review","volume":"22","author":"Hamada","year":"2018","journal-title":"Int J Tuberc Lung Dis"},{"issue":"10","key":"10.1016\/j.ijid.2019.07.004_bib0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002152","article-title":"The global burden of latent tuberculosis infection: a re-estimation using mathematical modelling","volume":"13","author":"Houben","year":"2016","journal-title":"PLoS Med"},{"issue":"34","key":"10.1016\/j.ijid.2019.07.004_bib0085","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000004126","article-title":"Impact of 12-dose regimen for latent tuberculosis infection: Treatment completion rate and cost-effectiveness in Taiwan","volume":"95","author":"Huang","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"10.1016\/j.ijid.2019.07.004_bib0090","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jmii.2013.07.008","article-title":"Prevalence of latent tuberculosis infection in BCG-vaccinated healthcare workers by using an interferon-gamma release assay and the tuberculin skin test in an intermediate tuberculosis burden country","volume":"48","author":"Hung","year":"2015","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.ijid.2019.07.004_bib0095","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2471\/BLT.17.199414","article-title":"National policies on the management of latent tuberculosis infection: Review of 98 countries","volume":"96","author":"Jagger","year":"2018","journal-title":"Bull World Health Organ"},{"issue":"11","key":"10.1016\/j.ijid.2019.07.004_bib0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0186588","article-title":"Trend and treatment status of latent tuberculosis infection patients in Japan \u2013 analysis of Japan TB surveillance data","volume":"12","author":"Kawatsu","year":"2017","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.ijid.2019.07.004_bib0105","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/trstmh\/trx015","article-title":"Latent TB infection and pulmonary TB disease among patients with diabetes mellitus in Bandung, Indonesia","volume":"111","author":"Koesoemadinata","year":"2017","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.ijid.2019.07.004_bib0110","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S1473-3099(18)30625-X","article-title":"Global, regional, and national burden of tuberculosis, 1990\u20132016: results from the global burden of diseases, injuries, and risk factors 2016 study","volume":"18","author":"Kyu","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"10.1016\/j.ijid.2019.07.004_bib0115","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1093\/cid\/ciw836","article-title":"Diabetes mellitus and latent tuberculosis infection: a systemic review and metaanalysis","volume":"64","author":"Lee","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.ijid.2019.07.004_bib0120","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.arcmed.2015.03.009","article-title":"Associated risk factors for latent tuberculosis infection in subjects with diabetes","volume":"46","author":"Martinez-Aguilar","year":"2015","journal-title":"Arch Med Res"},{"issue":"10","key":"10.1016\/j.ijid.2019.07.004_bib0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0164034","article-title":"Prevalence of latent tuberculosis among health care workers in high burden countries: a systematic review and meta-analysis","volume":"11","author":"Nasreen","year":"2016","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.ijid.2019.07.004_bib0130","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1590\/S1806-37562016000000001","article-title":"Prevalence of latent Mycobacterium tuberculosis infection in prisoners","volume":"42","author":"Navarro","year":"2016","journal-title":"J Bras Pneumol"},{"issue":"2","key":"10.1016\/j.ijid.2019.07.004_bib0135","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.amepre.2018.04.030","article-title":"Isoniazid-rifapentine for latent tuberculosis infection: a systematic review and meta-analysis","volume":"55","author":"Njie","year":"2018","journal-title":"Am J Prev Med"},{"issue":"6","key":"10.1016\/j.ijid.2019.07.004_bib0140","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1183\/13993003.01012-2016","article-title":"Correlates of tuberculosis risk: predictive biomarkers for progression to active tuberculosis","volume":"48","author":"Petruccioli","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ijid.2019.07.004_bib0145","first-page":"A3989","article-title":"Latent tuberculosis infection screening in health care workers in community lung health center in Bandung, Indonesia","volume":"195","author":"Ratnawati","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ijid.2019.07.004_bib0150","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1756-0500-5-7","article-title":"Adherence to isoniazid preventive therapy in Indonesian children: a quantitative and qualitative investigation","volume":"5","author":"Rutherford","year":"2012","journal-title":"BMC Res Notes"},{"issue":"7","key":"10.1016\/j.ijid.2019.07.004_bib0155","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1093\/cid\/cix505","article-title":"High rate of treatment completion in program settings with 12-dose weekly isoniazid and rifapentine (3HP) for latent Mycobacterium tuberculosis infection","volume":"65","author":"Sandul","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.ijid.2019.07.004_bib0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0169539","article-title":"Comparison of TST and IGRA in diagnosis of latent tuberculosis infection in a high TB-burden setting","volume":"12","author":"Sharma","year":"2017","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.ijid.2019.07.004_bib0165","doi-asserted-by":"crossref","first-page":"686","DOI":"10.5588\/ijtld.17.0598","article-title":"Diabetes and pre-diabetes among household contacts of tuberculosis patients in India: is it time to screen them all?","volume":"22","author":"Shivakumar","year":"2018","journal-title":"Int J Tuberc Lung Dis"},{"issue":"6","key":"10.1016\/j.ijid.2019.07.004_bib0170","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1086\/520983","article-title":"The effectiveness of a 9-month regimen of isoniazid alone versus 3- and 4-month regimens of isoniazid plus rifampin for treatment of latent tuberculosis infection in children: results of an 11-year randomized study","volume":"45","author":"Spyridis","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"23","key":"10.1016\/j.ijid.2019.07.004_bib0175","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa1104875","article-title":"Three months of rifapentine and isoniazid for latent tuberculosis infection","volume":"365","author":"Sterling","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2019.07.004_bib0180","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.tube.2018.05.013","article-title":"Twelve-dose weekly rifapentine plus isoniazid for latent tuberculosis infection: a multicentre randomised controlled trial in Taiwan","volume":"111","author":"Sun","year":"2018","journal-title":"Tuberculosis (Edinb)."},{"key":"10.1016\/j.ijid.2019.07.004_bib0185","doi-asserted-by":"crossref","first-page":"601737","DOI":"10.1155\/2013\/601737","article-title":"Interferon-gamma release assays versus tuberculin skin testing for the diagnosis of latent tuberculosis infection: An overview of the evidence","volume":"2013","author":"Trajman","year":"2013","journal-title":"Pulm Med"},{"issue":"3","key":"10.1016\/j.ijid.2019.07.004_bib0190","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofx137","article-title":"Risk of tuberculosis infection and disease for health care workers: an updated meta-analysis","volume":"4","author":"Uden","year":"2017","journal-title":"Open Forum Infect Dis"},{"issue":"11","key":"10.1016\/j.ijid.2019.07.004_bib0195","first-page":"S65","article-title":"Toward safe and reachable preventive therapy for latent tuberculosis infection: a multicentre randomised controlled trial I Taiwan. OA01-206-25","volume":"22","author":"Wang","year":"2018","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ijid.2019.07.004_bib0200","series-title":"The End TB Strategy","author":"World Health Organization","year":"2015"},{"key":"10.1016\/j.ijid.2019.07.004_bib0205","series-title":"Report of the Global Consultation on the Programmatic Management of Latent Tuberculosis Infection","author":"World Health Organization","year":"2016"},{"key":"10.1016\/j.ijid.2019.07.004_bib0210","series-title":"Country TB profile","author":"World Health Organization","year":"2017"},{"key":"10.1016\/j.ijid.2019.07.004_bib0215","series-title":"Global Tuberculosis Report","author":"World Health Organization","year":"2018"},{"key":"10.1016\/j.ijid.2019.07.004_bib0220","series-title":"Latent tuberculosis infection. Updated and consolidated guidelines for programmatic management","author":"World Health Organization","year":"2018"},{"issue":"10035","key":"10.1016\/j.ijid.2019.07.004_bib0225","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1016\/S0140-6736(15)01316-1","article-title":"A blood RNA signature for tuberculosis disease risk: a prospective cohort study","volume":"387","author":"Zak","year":"2016","journal-title":"Lancet"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971219302899?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971219302899?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:45:37Z","timestamp":1761119137000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971219302899"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":45,"alternative-id":["S1201971219302899"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2019.07.004","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnosis and management of latent tuberculosis infection in Asia: Review of current status and challenges","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2019.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}